● Covered by 1 source · 1 reportLow impact1 neutral
Pentagon withdraws new testosterone screening policy for military personnel
Key points
- Pentagon rescinded new testosterone screening guidance on September 3.
- The guidance was released on September 2, following a July announcement.
- Pentagon stated the withdrawal was for updates, with an interim guidance in effect.
- The original guidance included questionnaires and blood tests for hormone levels.
Policy Withdrawal
The Pentagon withdrew its clinical guidance document for mandatory testosterone screening for military personnel on September 3. This withdrawal occurred just one day after the document, titled “Clinical Guidance for Health and Human Performance Optimization,” was released on September 2.
Background of the Policy
Defense Secretary Pete Hegseth initially announced the new policy in July, stating that the US military would begin mandatory testosterone screening for its personnel. The detailed clinical guidance followed this announcement, outlining the procedures for the screenings.
Reason for Rescission
The Pentagon stated that the document was temporarily rescinded to allow for updates. An accompanying statement by spokesperson Sean Parnell was also removed. The Pentagon declined to provide further details on what specific updates were needed or why the guidance required such rapid revision after its release.
Interim Guidance and Future Plans
Despite the withdrawal of the specific guidance, an interim guidance remains in effect. The Pentagon affirmed its commitment to addressing hormone deficiencies and protecting service members' health, stating that the final clinical guidance will be issued shortly.
Details of the Rescinded Guidance
Reports indicated that the rescinded guidelines included a questionnaire for men aged 30 and older, which could lead to blood tests for testosterone levels and potential hormone therapy. Women were also to be screened via a questionnaire for hormonal imbalances, potentially leading to treatment.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
Reporting from
The Pentagon rescinded its recently issued clinical guidance for mandatory testosterone screening for military personnel, citing a need for updates. The policy, announced in July, was withdrawn just one day after its release, with an interim guidance remaining in effect.